UFC flyweight Alibi Idiris has had a win stricken from his professional record.
He’s also been benched for a period of 12 months following a positive drug test.
Kazakhstan’s Idiris (10-1, 1NC), 31, a competitor on The Ultimate Fighter 33, tested positive for hydrochlorothiazide, a diuretic, in an in-competition drug test whose sample was collected on February 21, 2026.
Hydrochlorothiazide is banned at all times under the UFC’s Anti-Doping Policy.
As a result of the positive test, Idiris’ unanimous decision win over Ode Osbourne at UFC Houston on Feb. 21 has been overturned to a No Contest. Additionally, CSAD (Combat Sports Anti-Doping) has shelved the fighter 12 months, after he confessed to using the substance to help make weight for the fight.
Due to knowingly using a banned substance, despite his cooperation in the ensuing investigation and admission, Idiris did not receive any reduction to his suspension, which will expire on February 21, 2027.
CSAD also provided the relevant records to the Texas Department of Licensing and Regulations (TDLR), who are responsible for amending the record of the fight. TDLR may also choose to adjudicate the drug test failure separately (beyond the CSAD suspension), as they retain jurisdiction over the fight.
Alibi Idiris fought in The Ultimate Fighter 33 finale, losing to Joseph Morales at UFC 319 last August in his only other UFC appearance.
